Rabies vaccine potency control: Comparison of ELISA systems for antigenicity testing

Journal of Virological Methods

Volumn 58, Issue 1-2, 1996, Pages 111-119

  Rooijakkers, E J M ^a   Uittenbogaard, J P ^b   Groen, J ^a   Osterhaus, A D M E ^a,c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Antigenicity; ELISA; Potency assay; Rabies vaccine

Indexed keywords

MONOCLONAL ANTIBODY; RABIES VACCINE; VIRUS GLYCOPROTEIN; VIRUS NUCLEOPROTEIN;

ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABIES; VACCINE PRODUCTION;

EID: 0030049407     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-0934(95)01999-5     Document Type: Article

References (30)

1. Atanasiu, P., Perrin, P. and Delagneau, J.F. (1980) Use of an enzyme immunoassay with protein A for rabies antigen and antibody determinations. Dev. Biol. Stand. 46, 207-215.
2. Barth, R., Diderrich, G. and Weinmann, E. (1988) NIH test, a problematic method for testing potency of inactivated rabies vaccine. Vaccine 6, 369-377.
3. Barth, R., Gross-Albenhausen, E., Jaeger, O. and Milcke, L. (1981) The antibody-binding test: a useful method for quantitative determination of inactivated rabies virus antigen. J. Biol. Stand. 9, 81-89.
4. Barth, R., Franke, V., Müller, H. and Weinmann, E. (1990) Purified chick-embryo-cell (PCEC) rabies vaccine: its potency performance in different test systems and in humans. Vaccine 8, 41-48.
5. Bayer, E.A. and Wilchek, M. (1980) The use of avidin-biotin complex as a tool in molecular biology. Methods Biochem. Anal. 26, 1-45.
6. Bliss, C.I. (1935) The calculation of the dose-mortality curve. Ann. Appl. Biol. 22, 134-167.
7. Bunschoten, H., Gore, M., Claassen, I.J.Th.M., UytdeHaag, F.G.C.M., Dietzschold, B., Wunner, W.H. and Osterhaus, A.D.M.E. (1989) Characterization of a new virus-neutralizing epitope that denotes a sequential determinant on the rabies virus glycoprotein. J. Gen. Virol. 70, 291-298.
8. Dietzschold, B., Gore, M., Casali, P., Ueki, Y., Rupprecht, C.E., Notkins, A.L. and Koprowski, H. (1990) Biological characterization of human monoclonal antibodies to rabies virus. J. Virol. 64, 3087-3090.
9. European Pharmacopoeia (1985) Vaccinum rabiei inactivatum ad usum veterinarium. In: Monograph European Pharmacopoeia. 2nd Edn, part 11/9, 451.
10. Ferguson, M. and Heath, A. (1992) Report of a collaborative study to assess the determination of glycoprotein antigen content of rabies vaccines for human use. Biologicals 20, 143-154.
11. Ferguson, M. and Schild, G.C. (1982) A single radial immunodiffusion technique for the assay of rabies glycoprotein antigen: application for potency tests of vaccines against rabies. J. Gen. Virol. 59, 197-201.
12. Ferguson, M., Seagroatt, V. and Schild, G. (1984) A collaborative study on the use of single radial immunodiffusion for the assay of rabies virus glycoprotein. J. Biol. Stand. 12, 283-294.
13. Groen, J., Van der Groen, G., Hoofd, G. and Osterhaus, A.D.M.E. (1989) Comparison of immunofluorescence and enzyme-linked immunosorbent assays for the serology of hantavirus infections. J. Virol. Meth. 23, 195-203.
14. Hendriksen, C.F.M., Slob, W., Van der Gun, J.W., Westendorp, J.H.L., Den Bieman, M., Hesp, A. and Van Zutphen, L.F.M. (1994) Immunogenicity testing of diphtheria and tetanus vaccines by using isogenic mice with possible implications for potency testing. Lab. Anim. 28, 121-129.
15. Hong, H.A., Rooijakkers, E.J.M., Ke, N.T., Groen, J. and Osterhaus, A.D.M.E. (1994) Methods for the purification of equine rabies immunoglobulin: effects on the yield and biological activity. Biologicals 22, 1-6.
16. Lafon, M., Perrin, P., Versmisse, P. and Sureau, P. (1985) Use of monoclonal antibody for quantitation of rabies vaccine glycoprotein by enzyme immunoassay. J. Biol. Stand. 13, 295-301.
17. Lorenz, R.J. and Bögel, K. (1973) Methods of calculation. In: M.M. Kaplan and H. Koprowski (Eds.), Laboratory Techniques in Rabies, 3rd Edn., World Health Organization, Geneva, pp. 321-335.
18. Lyng, J., Wies Bentzon, M., Ferguson, M. and Fitzgerald, E.A. (1992) Rabies vaccine standardization: International collaborative study for the characterization of the fifth International Standard for rabies vaccine. Biologicals 20, 301-313.
19. Nakane, P.K. and Kawaoi, A. (1974) Peroxidase-labeled antibody. A new method of conjugation. J. Histochem. Cytochem. 22, 1084-1091.
20. Osterhaus, A.D.M.E., Groen, J., UytdeHaag, F.G.C.M., Bunschoten, E.J., De Groot, I.G.M., Van der Meer, R. and Van Steenis, G. (1990) Quantification of rabies virus vaccine glycoprotein by ELISA with monoclonal antibodies: correlation with single radial diffusion and the induction of anti-viral antibodies and protection in mice. In: O. Thraenhart, H. Koprowski, K., Bögel and P. Sureau (Eds.), Progress in Rabies Control, Staples Printers Rochester Ltd., Rochester, pp. 320-323.
21. Osterhaus, A.D.M.E., Van Wezel, A.L., Van Steenis, G., Hazendonk, A.G. and Drost, G.A., (1982) Production and potential use of monoclonal antibodies against polioviruses. Dev. Biol. Stand. 50, 221-223.
22. Perrin, P., Morgeaux, S. and Sureau, P. (1990) In vitro rabies vaccine potency appraisal by ELISA: Advantages of the immunocapture method with a neutralizing anti-glycoprotein monoclonal antibody. Biologicals 18, 321-330.
23. Rooijakkers, E.J.M., Groen, J., Uittenbogaard, J.P., Van Herwijnen, J.R. and Osterhaus, A.D.M.E. (1995) Development and evaluation of alternative testing methods for the in vivo NIH potency test used for the quality control of inactivated rabies vaccines. Dev. Biol. Stand. 86, 137-145.
24. Seligmann, E.B. Jr. (1973) The NIH test for potency. In: M.M. Kaplan and H. Koprowski (Eds.), Laboratory Techniques in Rabies. 3rd Edn., World Health Organization, Geneva, pp. 279-286.
25. Sureau, P. (1992) Contribution to rabies prevention. Vaccine 10, 896-899.
26. Thraenhart, O. and Ramakrishnan, K. (1989) Standardization of an enzyme immunoassay for the in vitro potency assay of inactivated tissue culture rabies vaccines: determination of the rabies virus glycoprotein with polyclonal antisera. J. Biol. Stand. 17, 291-301.
27. Thraenhart, O. and Ramakrishnan, K. (1990) Essen-ELISA, a standardized method for the potency assay of rabies vaccines and in process preparations. In: O. Thraenhart, H. Koprowski, K. Bögel and P. Sureau (Eds.), Progress in Rabies Control, pp. 324-345, Staples Printers Rochester Ltd., Rochester.
28. Van der Marel, P. and Van Wezel, A.L. (1981) Quantitative determination of rabies antigen by ELISA. Dev. Biol. Stand. 50, 267-275.
29. WHO (1992) WHO Expert Committee on Rabies, 8th report. WHO Technical Report Series 824, 1-84.
30. Wunderli, P.S., Shaddock, J.H., Schmid, D.S., Miller, T.J. and Baer, G.M. (1991) The protective role of humoral neutralizing antibody in the NIH potency test for rabies vaccines. Vaccine 9, 638-642.